rs2272903
Positions:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The XR_007059923.1(LOC124901490):n.125+44C>T variant causes a intron, non coding transcript change. The variant allele was found at a frequency of 0.126 in 1,600,400 control chromosomes in the GnomAD database, including 15,106 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2795 hom., cov: 32)
Exomes 𝑓: 0.12 ( 12311 hom. )
Consequence
LOC124901490
XR_007059923.1 intron, non_coding_transcript
XR_007059923.1 intron, non_coding_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.23
Genes affected
TFAP2B (HGNC:11743): (transcription factor AP-2 beta) This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 6-50818858-G-A is Benign according to our data. Variant chr6-50818858-G-A is described in ClinVar as [Benign]. Clinvar id is 1273651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LOC124901490 | XR_007059923.1 | n.125+44C>T | intron_variant, non_coding_transcript_variant | ||||
TFAP2B | NM_003221.4 | upstream_gene_variant | ENST00000393655.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TFAP2B | ENST00000344788.7 | c.-67G>A | 5_prime_UTR_variant | 1/4 | 3 | ||||
TFAP2B | ENST00000393655.4 | upstream_gene_variant | 1 | NM_003221.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.173 AC: 26273AN: 151822Hom.: 2792 Cov.: 32
GnomAD3 genomes
AF:
AC:
26273
AN:
151822
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.149 AC: 37476AN: 250704Hom.: 3292 AF XY: 0.149 AC XY: 20223AN XY: 135502
GnomAD3 exomes
AF:
AC:
37476
AN:
250704
Hom.:
AF XY:
AC XY:
20223
AN XY:
135502
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.122 AC: 176025AN: 1448460Hom.: 12311 Cov.: 28 AF XY: 0.123 AC XY: 88848AN XY: 721588
GnomAD4 exome
AF:
AC:
176025
AN:
1448460
Hom.:
Cov.:
28
AF XY:
AC XY:
88848
AN XY:
721588
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.173 AC: 26288AN: 151940Hom.: 2795 Cov.: 32 AF XY: 0.179 AC XY: 13294AN XY: 74268
GnomAD4 genome
AF:
AC:
26288
AN:
151940
Hom.:
Cov.:
32
AF XY:
AC XY:
13294
AN XY:
74268
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
632
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Char syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at